After Compound C inhibited the AMPK pathway, the capacity of CD8+ T cells to secrete TNF-α, IL-2, and IFN-γ was reduced, thereby making it an unavailable infiltrative environment for lung cancer cells. The gene discussed is CD8A; the disease is lung cancer.